The diagnostic value of RNA oncomarkers in evaluation of malignant breast tumors

   
Globa A.G.1 , Alekseev Y.I.1, Varlamov D.A.1, Vishnevsky A.A.2

1. Institute of Agricultural Biotechnology, Russian Academy of Agricultural Sciences, ZAO Sintol
2. Vishnevsky Institute of Surgery
Section: Short Communication
DOI: 10.18097/PBMC20115706677      PubMed Id: 22359925
Year: 2011  Volume: 57  Issue: 6  Pages: 677-680
The levels of the RNA oncomarkers, telomerase (hTERT), cytokeratin-19 (CK-19) and mammaglobin (MAM) have been investigated in capillary blood of female patients with mammary ductal carcinoma. The study revealed overexpression of all three factors in patients with this pathology. This overexpression was not found in healthy donors and female patients with mammary fibroadenoma. Levels of the RNA oncomarkers return to the normal level within 10 days after successful tumor resection. These results have been used for the development of diagnostic kits, which may be applicable for differential diagnostics, screening and postoperation monitoring of patients with malignant breast tumors
Download PDF:  
Keywords: Polymerase chain reaction, telomerase, mammaglobin, oncomarkers, carcinoma
Citation:

Globa, A. G., Alekseev, Y. I., Varlamov, D. A., Vishnevsky, A. A. (2011). The diagnostic value of RNA oncomarkers in evaluation of malignant breast tumors. Biomeditsinskaya Khimiya, 57(6), 677-680.
This paper is also available as the English translation: 10.1134/S1990750812020060
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)